文献速递中医内科中药与中成药合理使用

中药介导的治疗性血管新生:心血管疾病治疗进展

Therapeutic angiogenesis mediated by traditional Chinese Medicine: Advances in cardiovascular disease treatment.
PubMed 文献 · J Ethnopharmacol · 2025-05-08

本综述系统分析PubMed中关于中药诱导血管新生治疗血管闭塞性疾病的研究,聚焦复方、单药、活性成分及相关信号通路。结果表明中药通过HIF/VEGF、PI3K/AKT、NOTCH、BMP/ALK和Apelin/APJ等通路促进内皮细胞增殖、迁移和成管,改善缺血血流。作者认为血管新生是血管闭塞性疾病的新策略,但需现代医学技术进一步优化临床应用。

要点

  • 中药复方、单药及单体成分通过多靶点调控血管新生。
  • HIF/VEGF、PI3K/AKT等通路是中药促血管新生的关键机制。
  • 中药促血管新生可改善缺血区血流,但临床转化需进一步验证。

核心结论

  • 中药通过多靶点血管新生调控机制对血管闭塞性疾病显示疗效,但需现代医学技术进一步优化临床应用并推进精准医学。

研究设计与样本

  • 系统分析PubMed中关于中药诱导血管新生治疗血管闭塞性疾病的研究,聚焦中药复方、单药、生物活性化合物及相关信号通路。

主要发现

  • 中药复方、单药及单体化合物通过HIF/VEGF、PI3K/AKT、NOTCH、BMP/ALK和Apelin/APJ等通路增强内皮细胞增殖、迁移和成管,改善缺血血流。

临床怎么用

  • 可将促进治疗性血管新生作为中药治疗血管闭塞性疾病(如卒中、外周动脉疾病)的潜在策略。

局限性

  • 需进一步研究利用现代医学技术优化临床应用并推进精准医学。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Traditional Chinese Medicine (TCM) shows growing potential as an adjunct or alternative therapy for vascular occlusion diseases (e.g., stroke, peripheral artery disease) by promoting therapeutic angiogenesis to restore blood flow in ischemic regions while minimizing side effects. AIMS OF THE STUDY: This review examines TCM-mediated angiogenesis mechanisms and therapeutic advances in vascular occlusion management, establishing a theoretical foundation for clinical translation and precision medicine development. MATERIALS AND METHODS: We systematically analyzed PubMed articles on TCM-induced angiogenesis in vascular occlusion diseases, focusing on herbal formulations, single herbs, bioactive compounds, and their associated signaling pathways. Search PubMed for studies investigating the role of Chinese herbal medicine (TCM), natural compounds, and herbal medicine in angiogenesis, while excluding research related to cancer, tumor, or oncological contexts. RESULTS: TCM formulas, individual herbs, and monomeric compounds enhance endothelial cell proliferation, migration, and tube formation via pathways such as HIF/VEGF, PI3K/AKT, NOTCH, BMP/ALK, and Apelin/APJ, improving ischemic blood flow. CONCLUSION: This review highlights angiogenesis as a novel strategy for vascular occlusive diseases and underscores TCM's efficacy through multi-target angiogenic regulation mechanism.However, further research using modern medical technologies is needed to optimize clinical application and advance precision medicine.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Zhang R, Wang Y, Jiang H, et al. Therapeutic angiogenesis mediated by traditional Chinese Medicine: Advances in cardiovascular disease treatment. J Ethnopharmacol. 2025. PMID: 40345269. doi:10.1016/j.jep.2025.119871

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。